Global Cytogenetics Market

Cytogenetics Comprehensive Study by Type (Consumables, Testing Kits, Media, and Reagents, Probes, Others (Affinity Reagents and Stains), Instruments, Software & Services), Application (Genetic Disorders, Cancer, Personalized Medicine, Others), End Users (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Others), Techniques (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Karyotyping, Immunohistochemistry, Others) Players and Region - Global Market Outlook to 2030

Cytogenetics Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cytogenetics
The cytogenetics is the branch of genetics, which studies the structure and behavior of chromosomes and their relation to human disease as well as disease processes. Throughout the last three decades, the significance of clinical cytogenetics to the practice of gynecology and obstetrics has radically increased as clinical cytogenetics has a direct effect on the diagnosis, management, and prevention of many disorders, which are caused by chromosome aberrations. For several chromosomes disorders, physicians face medicolegal responsivities in the areas of screening, counseling, and diagnosis. Therefore, gynecologists and obstetricians must have knowledge about the human chromosome constitution and be able to apply basic principles of chromosome behavior to clinical practice.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.5%


The key players are targeting the innovations of the Solutions with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions to maintain their presence in the market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cytogenetics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Agilent Technologies, Inc. (United States), Applied Spectral Imaging, Inc. (United States), Empire Genomics, LLC. (United States), Illumina, Inc. (United States), FUJIFILM Irvine Scientific, Inc. (United States), OPKO Health, Inc. (United States), PerkinElmer Inc. (United States) and Sysmex Corporation (Oxford Gene Technology) (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thermo Fisher Scientific, Inc. (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland) and MetaSystems (United States).

Segmentation Overview
AMA Research has segmented the market of Global Cytogenetics market by Type (Consumables, Testing Kits, Media, and Reagents, Probes, Others (Affinity Reagents and Stains), Instruments and Software & Services), Application (Genetic Disorders, Cancer, Personalized Medicine and Others) and Region.



On the basis of geography, the market of Cytogenetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Clinical & Research Laboratories will boost the Cytogenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Techniques, the sub-segment i.e. Comparative Genomic Hybridization will boost the Cytogenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The transition from Fish to Array-Based Techniques

Market Growth Drivers:
Increasing Incidence of Genetic Disorders and Cancer, Growing Focus on Targeted Cancer Treatment, Increasing Aging Population and Subsequent Rise in Prevalence of Chronic Diseases and Increasing Penetration of Molecular Cytogenetics in Clinical Pathological Testing

Challenges:
Lack of Availability of Skilled Professionals

Restraints:
High Cost of Advanced Instruments and Unfavorable Reimbursement Scenario

Opportunities:
Untapped Emerging Markets in Asia Pacific

Market Leaders and their expansionary development strategies
On December 12, 2023, Karyomedix, a leading provider of cytogenetic testing services, announced a strategic partnership with Genetech, a global leader in molecular diagnostics. The partnership aims to combine Karyomedix's expertise in cytogenetics with Genetech's advanced molecular testing capabilities to offer comprehensive genetic testing solutions for patients with a variety of medical conditions.
On November 15, 2023, Counsyl launched an expanded carrier screening panel that now includes testing for over 300 genetic conditions. This expansion allows Counsyl to provide more comprehensive carrier screening to couples planning pregnancy, helping them identify potential risks for their future children.


Key Target Audience
Cytogenetics Companies, Research & Consulting Firms, Cytogenetics Instruments Manufacturers, Cytogenetics Software & Services Providers, Regulatory Bodies & Government Bodies and Downstream Vendors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Consumables
  • Testing Kits, Media, and Reagents
  • Probes
  • Others (Affinity Reagents and Stains)
  • Instruments
  • Software & Services
By Application
  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Others
By End Users
  • Clinical & Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

By Techniques
  • Comparative Genomic Hybridization
  • Fluorescence in Situ Hybridization
  • Karyotyping
  • Immunohistochemistry
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Genetic Disorders and Cancer
      • 3.2.2. Growing Focus on Targeted Cancer Treatment
      • 3.2.3. Increasing Aging Population and Subsequent Rise in Prevalence of Chronic Diseases
      • 3.2.4. Increasing Penetration of Molecular Cytogenetics in Clinical Pathological Testing
    • 3.3. Market Challenges
      • 3.3.1. Lack of Availability of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. The transition from Fish to Array-Based Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Cytogenetics, by Type, Application, End Users, Techniques and Region (value) (2018-2023)
    • 5.1. Introduction
  • 6. Cytogenetics: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Abbott Laboratories (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Agilent Technologies, Inc. (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Applied Spectral Imaging, Inc. (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Empire Genomics, LLC. (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Illumina, Inc. (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. FUJIFILM Irvine Scientific, Inc. (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. OPKO Health, Inc. (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. PerkinElmer Inc. (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Sysmex Corporation (Oxford Gene Technology) (Japan)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
  • 7. Global Cytogenetics Sale, by Type, Application, End Users, Techniques and Region (value) (2025-2030)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Research Programs/Design for This Report
  • Table 11. Key Data Information from Secondary Sources
  • Table 12. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 5. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 6. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 7. Agilent Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 8. Applied Spectral Imaging, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 9. Applied Spectral Imaging, Inc. (United States) Revenue: by Geography 2023
  • Figure 10. Empire Genomics, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 11. Empire Genomics, LLC. (United States) Revenue: by Geography 2023
  • Figure 12. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 13. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 14. FUJIFILM Irvine Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 15. FUJIFILM Irvine Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 16. OPKO Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. OPKO Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 18. PerkinElmer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. PerkinElmer Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Sysmex Corporation (Oxford Gene Technology) (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Sysmex Corporation (Oxford Gene Technology) (Japan) Revenue: by Geography 2023
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Agilent Technologies, Inc. (United States)
  • Applied Spectral Imaging, Inc. (United States)
  • Empire Genomics, LLC. (United States)
  • Illumina, Inc. (United States)
  • FUJIFILM Irvine Scientific, Inc. (United States)
  • OPKO Health, Inc. (United States)
  • PerkinElmer Inc. (United States)
  • Sysmex Corporation (Oxford Gene Technology) (Japan)
Additional players considered in the study are as follows:
Thermo Fisher Scientific, Inc. (United States) , Bio-Rad Laboratories, Inc. (United States) , F. Hoffmann-La Roche Ltd. (Switzerland) , MetaSystems (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 225 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cytogenetics Market Quantitative research analysis
Global Cytogenetics Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), Agilent Technologies, Inc. (United States), Applied Spectral Imaging, Inc. (United States), Empire Genomics, LLC. (United States), Illumina, Inc. (United States), FUJIFILM Irvine Scientific, Inc. (United States), OPKO Health, Inc. (United States), PerkinElmer Inc. (United States) and Sysmex Corporation (Oxford Gene Technology) (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The transition from Fish to Array-Based Techniques" is seen as one of major influencing trends for Cytogenetics Market during projected period 2023-2030.
The Cytogenetics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Cytogenetics Market to reach USD2997.15 Million by 2030.

Know More About Global Cytogenetics Market Report?

Have a Query? Click Here

Other Related Reports

Cosmetic Surgery Comprehensive Study by Type (Surgical Procedure, Non-surgical Procedure), Application (Liposuction, Eyelid and Nose Surgery, Body Contouring (Tummy Tuck, Breast Lift, Others), Facial...
$ 3650
Cell Expansion Comprehensive Study by Type (Consumables, Reagents, Media & Serum, Disposables (Tissue Culture Flasks, Bioreactor Accessories, and Others), Instruments (Cell Expansion Supporting Equip...
$ 3750
Acute Myeloid Leukemia Therapeutics Comprehensive Study by Type (Pipeline Drugs, Chemotherapy Drugs, Chemotherapy Regimens), Application (Hospitals, Clinics, Home Care), Drug Type (Bosutinib, Vidaza,...
$ 3750
Alopecia Comprehensive Study by Type (Oral treatment, Topical treatment, Other treatment), Application (Homecare Settings, Dermatology Clinics, Others (Salons)), Treatment (Vitamins and Supplements, ...
$ 3450
Endometriosis Treatment Comprehensive Study by Type (Gonadotropins releasing hormone agonists, Progestin, Non-steroidal anti-inflammatory drugs, Oral contraceptive pills), Application (Hospital pharm...
$ 3450
Pet Cancer Therapeutics Comprehensive Study by Type (Chemotherapy Drugs, Vaccines), Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, Squamous Cell Cancer, Others), Treatment (Chemotherapy,...
$ 3450